More Stories

Informist, Monday, Aug. 11, 2025

--Ipca Lab Apr-Jun net profit INR 2.62 bln 

--Analysts saw Ipca Lab Apr-Jun net profit INR 2.62 bln 

--Ipca Lab Apr-Jun net profit INR 2.62 bln vs INR 2.04 bln year ago 

--Ipca Lab Apr-Jun revenue INR 17.47 bln vs INR 15.66 bln year ago 

By Rizwan Ali

MUMBAI- Ipca Laboratories Ltd. met the Street's estimates for the net profit for the June quarter but sharply missed the estimate on the top line. The company's net profit rose 28% on year to INR 2.62 billion in the June quarter, matching the analysts' estimate. The top line grew faster pace than expenses during the quarter.

The company reported a revenue from operations at INR 17.47 billion for the June quarter, up 12% on year but significantly lower than the analysts' estimate of INR 23.16 billion. The total income of the company rose 12% on year to INR 17.72 billion for the reporting quarter. The company's income from exports jumped 18% to INR 7 billion and that from domestic formulation rose 10% on year to INR 9.61 billion. 

The company's total expense during the quarter came in at INR 14.15 billion, up 9% from INR 12.93 billion in the year-ago quarter. Other expenses of the company rose by 21% to 4.82 billion from INR 3.99 billion a year ago. The employee benefit expenses rose 13% on year to INR 4.10 billion. The cost of material consumed increased by 18% on year to INR 3.96 billion during the quarter. Finance costs declined 38% on year to INR 121 million.

The pharmaceutical company reported an earnings before interest, taxes, depreciation, and amortisation of INR 4.16 billion in the reporting quarter, up nearly 19% on year. The EBITDA margin expanded by 157 basis points on year to 23.82%. 

Ipca Labs reported no expenses for exceptional items for the reporting quarter, unlike the INR 2.82 billion it had reported in the trailing quarter.

Monday, shares of Ipca Laboratories closed at INR 1,336.70 on the NSE, down 3.6% from the previous close.  The company announced its results during market hours. End

IST, or Indian Standard Time, is five-and-a-half hours ahead of GMT

Edited by Saji George Titus

For users of real-time market data terminals, Informist news is available exclusively on the NSE Cogencis WorkStation.

Cogencis news is now Informist news. This follows the acquisition of Cogencis Information Services Ltd by NSE Data & Analytics Ltd, a 100% subsidiary of the National Stock Exchange of India Ltd. As a part of the transaction, the news department of Cogencis has been sold to Informist Media Pvt Ltd.

Informist Media Tel +91 (22) 6985-4000 /+91 (11) 4220-1000

Send comments to feedback@informistmedia.com

© Informist Media Pvt. Ltd. 2025. All rights reserved.